← Back to Search

Other

Plant-Based Diet for Early Stage Multiple Myeloma

N/A
Waitlist Available
Led By Urvi Shah, MD
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Confirmed diagnosis of MGUS or SMM
ECOG performance status of 0-3
Must not have
Mental impairment leading to inability to cooperate
Non English speaking
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether a plant-based diet is feasible and effective for people with early stage multiple myeloma.

Who is the study for?
This trial is for overweight adults with MGUS or SMM who have a BMI of 25 or higher, an M spike ≥0.2 g/dL, and are willing to learn plant-based cooking. Excluded are those with severe allergies, current participation in other studies or dietary programs, certain medical conditions as judged by the investigator, non-English speakers, and those already on vegan diets.
What is being tested?
The study is testing the feasibility and effectiveness of a plant-based diet in preventing multiple myeloma among participants with MGUS or SMM. It will measure weight loss adherence to the diet's practicality and its impact on quality of life.
What are the potential side effects?
Since this trial involves a dietary intervention (plant-based meals), side effects may be minimal but could include digestive changes due to new foods introduced into the diet.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with MGUS or SMM.
Select...
I can care for myself but may not be able to do heavy physical work.
Select...
My condition involves abnormal fluid production.
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am mentally capable of following study procedures.
Select...
I do not speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Patient adherence to the diet
Weight loss- body mass index (BMI) reduction

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Plant-based mealsExperimental Treatment1 Intervention
Patients who will be administered a whole-foods plant-based diet for 12 weeks with nutrition counselling for 24 weeks.Participants will be asked to complete a survey via MSK Engage and a notification will be sent via email notification.

Find a Location

Who is running the clinical trial?

Memorial Sloan Kettering Cancer CenterLead Sponsor
1,979 Previous Clinical Trials
599,815 Total Patients Enrolled
Urvi Shah, MDPrincipal InvestigatorMemorial Sloan Kettering Cancer Center
3 Previous Clinical Trials
271 Total Patients Enrolled

Media Library

Plant based meals (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04920084 — N/A
Monoclonal Gammopathy Research Study Groups: Plant-based meals
Monoclonal Gammopathy Clinical Trial 2023: Plant based meals Highlights & Side Effects. Trial Name: NCT04920084 — N/A
Plant based meals (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04920084 — N/A
~2 spots leftby Jun 2025